ANO1 and pancreatic neoplasm: Pharmacological inhibition of ANO1 by T16Ainh-A01, a selective ANO1 inhibitor, reduced proliferation of interstitial cells of Cajal (ICC) and CFPAC-1 pancreatic cancer cells expressing endogenous ANO1 [15].